Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

Abstract

Repeated ranibizumab treatment was not associated with impaired macular perfusion in our study cohort. Because our data do not suggest a harmful effect of anti-vascular endothelial growth factor therapy on capillary integrity, patients with severe microangiopathy and advanced capillary dropout should not be denied these treatments.